These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25835179)

  • 1. Significant association of TP53 Arg72Pro polymorphism in susceptibility to differentiated thyroid cancer.
    Khan MS; Pandith AA; Masoodi SR; Khan SH; Rather TA; Andrabi KI; Mudassar S
    Cancer Biomark; 2015; 15(4):459-65. PubMed ID: 25835179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
    Pandith AA; Shah ZA; Khan NP; Rasool R; Afroze D; Yousuf A; Wani S; Siddiqi M
    Cancer Genet Cytogenet; 2010 Dec; 203(2):263-8. PubMed ID: 21156242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of codon 72 Arg > Pro single nucleotide polymorphism in TP53 gene in the risk of kangri cancer: a case control study in Kashmir.
    Pandith AA; Khan NP; Rashid N; Azad N; Zaroo I; Hafiz A; Siddiqi MA
    Tumour Biol; 2012 Aug; 33(4):927-33. PubMed ID: 22249977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
    Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
    Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predisposition in an ethnic Kashmiri population.
    Sameer AS; Shah ZA; Syeed N; Banday MZ; Bashir SM; Bhat BA; Siddiqi MA
    Genet Mol Res; 2010 Apr; 9(2):651-60. PubMed ID: 20449797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
    Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
    Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous proline at codon 72 of p53 as a potential risk factor favoring the development of undifferentiated thyroid carcinoma.
    Boltze C; Roessner A; Landt O; Szibor R; Peters B; Schneider-Stock R
    Int J Oncol; 2002 Nov; 21(5):1151-4. PubMed ID: 12370767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer risk in relation to TP53 codon 47 and codon 72 polymorphism in Bangladeshi population.
    Mostaid MS; Ahmed MU; Islam MS; Bin Sayeed MS; Hasnat A
    Tumour Biol; 2014 Oct; 35(10):10309-17. PubMed ID: 25034526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
    Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Arg72Pro of P53 polymorphism with colorectal cancer susceptibility risk in Malaysian population.
    Aizat AA; Shahpudin SN; Mustapha MA; Zakaria Z; Sidek AS; Abu Hassan MR; Ankathil R
    Asian Pac J Cancer Prev; 2011; 12(11):2909-13. PubMed ID: 22393962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TP53 codon 72 Arg/Arg polymorphism is associated with a higher risk for inflammatory bowel disease development.
    Volodko N; Salla M; Eksteen B; Fedorak RN; Huynh HQ; Baksh S
    World J Gastroenterol; 2015 Sep; 21(36):10358-66. PubMed ID: 26420962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas.
    Lima-Ramos V; Pacheco-Figueiredo L; Costa S; Pardal F; Silva A; Amorim J; Lopes JM; Reis RM
    Cancer Genet Cytogenet; 2008 Jan; 180(1):14-9. PubMed ID: 18068527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 codon 72 polymorphism is associated with pancreatic cancer risk in males, smokers and drinkers.
    Sonoyama T; Sakai A; Mita Y; Yasuda Y; Kawamoto H; Yagi T; Yoshioka M; Mimura T; Nakachi K; Ouchida M; Yamamoto K; Shimizu K
    Mol Med Rep; 2011; 4(3):489-95. PubMed ID: 21468597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer.
    Rogounovitch TI; Saenko VA; Ashizawa K; Sedliarou IA; Namba H; Abrosimov AY; Lushnikov EF; Roumiantsev PO; Konova MV; Petoukhova NS; Tchebotareva IV; Ivanov VK; Chekin SY; Bogdanova TI; Tronko MD; Tsyb AF; Thomas GA; Yamashita S
    Oncol Rep; 2006 Apr; 15(4):949-56. PubMed ID: 16525684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible Impact of RET Polymorphism and Its Haplotypic Association Modulates the Susceptibility to Thyroid Cancer.
    Khan MS; Pandith AA; Iqbal M; Naykoo NA; Khan SH; Rather TA; Mudassar S
    J Cell Biochem; 2015 Aug; 116(8):1712-8. PubMed ID: 25736215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A; Jassem E; Dziadziuszko R; Borg A; Limon J; Kobierska-Gulida G; Rzyman W; Jassem J
    Lung Cancer; 2006 Apr; 52(1):9-14. PubMed ID: 16499995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis.
    Wu B; Guo D; Guo Y
    Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TP53 codon 72 polymorphism in adult soft tissue sarcomas.
    Almeida PS; Manoel WJ; Reis AA; Silva ER; Martins E; Paiva MV; Fraga AC; Saddi VA
    Genet Mol Res; 2008; 7(4):1344-52. PubMed ID: 19065769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
    Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
    World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 codon 72 polymorphism is associated with susceptibility to hepatocellular carcinoma in the Turkish population: a case-control study.
    Sümbül AT; Akkız H; Bayram S; Bekar A; Akgöllü E; Sandıkçı M
    Mol Biol Rep; 2012 Feb; 39(2):1639-47. PubMed ID: 21607615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.